These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21325097)

  • 1. The "new" marijuana.
    Wells DL; Ott CA
    Ann Pharmacother; 2011 Mar; 45(3):414-7. PubMed ID: 21325097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rise in K2 use with varying clinical symptoms and the potential for ED crowding.
    Roy AA; DeNonno L; Becerra I; Chirurgi R; McCorkell P; Hassen GW
    Am J Emerg Med; 2015 Apr; 33(4):582. PubMed ID: 25662800
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings.
    Hermanns-Clausen M; Kneisel S; Szabo B; Auwärter V
    Addiction; 2013 Mar; 108(3):534-44. PubMed ID: 22971158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internet highs--seizures after consumption of synthetic cannabinoids purchased online.
    Tofighi B; Lee JD
    J Addict Med; 2012 Sep; 6(3):240-1. PubMed ID: 22824736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic Cannabinoid-Related Illnesses and Deaths.
    Trecki J; Gerona RR; Schwartz MD
    N Engl J Med; 2015 Jul; 373(2):103-7. PubMed ID: 26154784
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A teenager with agitation: higher than she should have climbed.
    Vearrier D; Osterhoudt KC
    Pediatr Emerg Care; 2010 Jun; 26(6):462-5. PubMed ID: 20531137
    [No Abstract]   [Full Text] [Related]  

  • 8. An accidental fatal intoxication with methoxetamine.
    Wikström M; Thelander G; Dahlgren M; Kronstrand R
    J Anal Toxicol; 2013; 37(1):43-6. PubMed ID: 23111916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010.
    Hoyte CO; Jacob J; Monte AA; Al-Jumaan M; Bronstein AC; Heard KJ
    Ann Emerg Med; 2012 Oct; 60(4):435-8. PubMed ID: 22575211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
    Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
    Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project.
    Hermanns-Clausen M; Kithinji J; Spehl M; Angerer V; Franz F; Eyer F; Auwärter V
    Drug Test Anal; 2016 Oct; 8(10):1030-1038. PubMed ID: 26768345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation.
    Young AC; Schwarz E; Medina G; Obafemi A; Feng SY; Kane C; Kleinschmidt K
    Am J Emerg Med; 2012 Sep; 30(7):1320.e5-7. PubMed ID: 21802885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
    Gudsoorkar VS; Perez JA
    Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers.
    Forrester MB; Haywood T
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):603-8. PubMed ID: 22571605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric sequelae of Spice, K2, and synthetic cannabinoid receptor agonists.
    Benford DM; Caplan JP
    Psychosomatics; 2011; 52(3):295. PubMed ID: 21565605
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical presentation of intoxication due to synthetic cannabinoids.
    Cohen J; Morrison S; Greenberg J; Saidinejad M
    Pediatrics; 2012 Apr; 129(4):e1064-7. PubMed ID: 22430444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre.
    Cairns R; Brown JA; Gunja N; Buckley NA
    Int J Drug Policy; 2017 May; 43():74-82. PubMed ID: 28343112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthetic cannabinoids: spread, addiction biology & current perspective of personal health hazard].
    Bonnet U; Mahler H
    Fortschr Neurol Psychiatr; 2015 Apr; 83(4):221-31. PubMed ID: 25893495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.
    White CM
    J Clin Pharmacol; 2017 Mar; 57(3):297-304. PubMed ID: 27610597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015.
    Keyes KM; Rutherford C; Hamilton A; Palamar JJ
    Drug Alcohol Depend; 2016 Sep; 166():159-67. PubMed ID: 27491817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.